Literature DB >> 23552413

Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin.

Cyrille Dreyfus1, Damian C Ekiert, Ian A Wilson.   

Abstract

We report the structural characterization of the first antibody identified to cross-neutralize multiple subtypes of influenza A viruses. The crystal structure of mouse antibody C179 bound to the pandemic 1957 H2N2 hemagglutinin (HA) reveals that it targets an epitope on the HA stem similar to those targeted by the recently identified human broadly neutralizing antibodies. C179 also inhibits the low-pH conformational change of the HA but uses a different angle of approach and both heavy and light chains.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552413      PMCID: PMC3676097          DOI: 10.1128/JVI.02975-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

2.  Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  Mol Immunol       Date:  2008-07-09       Impact factor: 4.407

3.  Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957.

Authors:  Junfeng Liu; David J Stevens; Lesley F Haire; Philip A Walker; Peter J Coombs; Rupert J Russell; Steven J Gamblin; John J Skehel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

4.  Highly conserved protective epitopes on influenza B viruses.

Authors:  Cyrille Dreyfus; Nick S Laursen; Ted Kwaks; David Zuijdgeest; Reza Khayat; Damian C Ekiert; Jeong Hyun Lee; Zoltan Metlagel; Miriam V Bujny; Mandy Jongeneelen; Remko van der Vlugt; Mohammed Lamrani; Hans J W M Korse; Eric Geelen; Özcan Sahin; Martijn Sieuwerts; Just P J Brakenhoff; Ronald Vogels; Olive T W Li; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Andrew B Ward; Ian A Wilson; Jaap Goudsmit; Robert H E Friesen
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

5.  Satisfying hydrogen bonding potential in proteins.

Authors:  I K McDonald; J M Thornton
Journal:  J Mol Biol       Date:  1994-05-20       Impact factor: 5.469

6.  A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.

Authors:  Saori Sakabe; Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Chairul A Nidom; Mai thi Quynh Le; Ryo Takano; Ritsuko Kubota-Koketsu; Yoshinobu Okuno; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  Antiviral Res       Date:  2010-09-16       Impact factor: 5.970

7.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  67 in total

1.  Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.

Authors:  Nicholas C Wu; Andrew J Thompson; Juhye M Lee; Wen Su; Britni M Arlian; Jia Xie; Richard A Lerner; Hui-Ling Yen; Jesse D Bloom; Ian A Wilson
Journal:  Science       Date:  2020-06-19       Impact factor: 47.728

Review 2.  Influenza virus antigenicity and broadly neutralizing epitopes.

Authors:  Gillian M Air
Journal:  Curr Opin Virol       Date:  2015-04-04       Impact factor: 7.090

3.  Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.

Authors:  Aleksandar Antanasijevic; Arnab Basu; Terry L Bowlin; Rama K Mishra; Lijun Rong; Michael Caffrey
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

4.  Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.

Authors:  Goran Bajic; Max J Maron; Yu Adachi; Taishi Onodera; Kevin R McCarthy; Charles E McGee; Gregory D Sempowski; Yoshimasa Takahashi; Garnett Kelsoe; Masayuki Kuraoka; Aaron G Schmidt
Journal:  Cell Host Microbe       Date:  2019-05-16       Impact factor: 21.023

5.  Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

Authors:  Sandhya Bangaru; Travis Nieusma; Nurgun Kose; Natalie J Thornburg; Jessica A Finn; Bryan S Kaplan; Hannah G King; Vidisha Singh; Rebecca M Lampley; Gopal Sapparapu; Alberto Cisneros; Kathryn M Edwards; James C Slaughter; Srilatha Edupuganti; Lilin Lai; Juergen A Richt; Richard J Webby; Andrew B Ward; James E Crowe
Journal:  JCI Insight       Date:  2016-07-07

6.  A common solution to group 2 influenza virus neutralization.

Authors:  Robert H E Friesen; Peter S Lee; Esther J M Stoop; Ryan M B Hoffman; Damian C Ekiert; Gira Bhabha; Wenli Yu; Jarek Juraszek; Wouter Koudstaal; Mandy Jongeneelen; Hans J W M Korse; Carla Ophorst; Els C M Brinkman-van der Linden; Mark Throsby; Mark J Kwakkenbos; Arjen Q Bakker; Tim Beaumont; Hergen Spits; Ted Kwaks; Ronald Vogels; Andrew B Ward; Jaap Goudsmit; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-11       Impact factor: 11.205

Review 7.  Structural insights into the design of novel anti-influenza therapies.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2018-02-02       Impact factor: 15.369

8.  Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.

Authors:  Seth J Zost; Jinhui Dong; Iuliia M Gilchuk; Pavlo Gilchuk; Natalie J Thornburg; Sandhya Bangaru; Nurgun Kose; Jessica A Finn; Robin Bombardi; Cinque Soto; Elaine C Chen; Rachel S Nargi; Rachel E Sutton; Ryan P Irving; Naveenchandra Suryadevara; Jonna B Westover; Robert H Carnahan; Hannah L Turner; Sheng Li; Andrew B Ward; James E Crowe
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

9.  New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.

Authors:  Arnab Basu; Aleksandar Antanasijevic; Minxiu Wang; Bing Li; Debra M Mills; Jessica A Ames; Peter J Nash; John D Williams; Norton P Peet; Donald T Moir; Mark N Prichard; Kathy A Keith; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 10.  Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

Authors:  Peter S Lee; Ian A Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.